Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0043 | 0.0497 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0497 | 0.0497 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0043 | 0.0497 | 0.5 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0043 | 0.0497 | 0.5 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.0497 | 0.0497 |
Onchocerca volvulus | 0.0503 | 1 | 1 | |
Brugia malayi | Common central domain of tyrosinase family protein | 0.0503 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0043 | 0.0497 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.074 | 0.074 |
Schistosoma mansoni | lipoxygenase | 0.0054 | 0.0723 | 0.0723 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.074 | 0.074 |
Leishmania major | hypothetical protein, conserved | 0.0043 | 0.0497 | 0.5 |
Mycobacterium leprae | Probable lipase LipE | 0.0043 | 0.0497 | 0.5 |
Mycobacterium ulcerans | lipase LipD | 0.0043 | 0.0497 | 0.5 |
Brugia malayi | Hypothetical tyrosinase-like protein C02C2.1 in chromosome III | 0.0503 | 1 | 1 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0043 | 0.0497 | 0.6716 |
Loa Loa (eye worm) | beta-lactamase | 0.0043 | 0.0497 | 0.0497 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.074 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.0043 | 0.0497 | 0.5 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.0497 | 0.0497 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0019 | 0 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.074 | 0.074 |
Loa Loa (eye worm) | hypothetical protein | 0.0503 | 1 | 1 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0043 | 0.0497 | 0.6716 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.0497 | 0.0497 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0497 | 0.0497 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0043 | 0.0497 | 0.5 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.0497 | 0.5 |
Onchocerca volvulus | 0.0043 | 0.0497 | 0.0497 | |
Loa Loa (eye worm) | tyrosinase 1 | 0.0503 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.074 | 1 |
Onchocerca volvulus | 0.0503 | 1 | 1 | |
Onchocerca volvulus | 0.0043 | 0.0497 | 0.0497 | |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0054 | 0.0723 | 0.9768 |
Brugia malayi | Hypothetical tyrosinase-like protein F21C3.2 in chromosome I | 0.0503 | 1 | 1 |
Loa Loa (eye worm) | ShTK domain-containing protein | 0.0503 | 1 | 1 |
Onchocerca volvulus | 0.0503 | 1 | 1 | |
Brugia malayi | beta-lactamase | 0.0043 | 0.0497 | 0.0497 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.0497 | 0.5 |
Onchocerca volvulus | 0.0503 | 1 | 1 | |
Schistosoma mansoni | tyrosinase precursor | 0.0503 | 1 | 1 |
Brugia malayi | Hypothetical tyrosinase-like protein C02C2.1 in chromosome III | 0.0503 | 1 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0043 | 0.0497 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0497 | 0.0497 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.074 | 0.074 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0497 | 0.0497 |
Schistosoma mansoni | tyrosinase precursor | 0.0503 | 1 | 1 |
Onchocerca volvulus | 0.0043 | 0.0497 | 0.0497 | |
Trichomonas vaginalis | esterase, putative | 0.0043 | 0.0497 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0497 | 0.0497 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.0497 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0497 | 0.0497 |
Toxoplasma gondii | ABC1 family protein | 0.0043 | 0.0497 | 0.5 |
Loa Loa (eye worm) | ShTK domain-containing protein | 0.0503 | 1 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.074 | 0.074 |
Brugia malayi | Hypothetical tyrosinase-like protein C02C2.1 in chromosome III | 0.0503 | 1 | 1 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0054 | 0.0723 | 0.9768 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.0497 | 0.0497 |
Mycobacterium ulcerans | beta-lactamase | 0.0043 | 0.0497 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.074 | 1 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0043 | 0.0497 | 0.0497 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0043 | 0.0497 | 0.5 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0043 | 0.0497 | 0.0497 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.0497 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0503 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.074 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.0497 | 0.5 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0278 | 0.5339 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.1689 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 1.2589 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 3.9811 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 25.929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.